$0.63
4.57% today
Nasdaq, Feb 05, 04:41 pm CET
ISIN
US23725P1003
Symbol
DRIO

DarioHealth Corp. Stock price

$0.60
-0.25 29.57% 1M
-0.37 38.13% 6M
-0.19 23.66% YTD
-1.35 69.23% 1Y
-7.78 92.84% 3Y
-8.39 93.33% 5Y
-64.20 99.07% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
-0.03 4.75%
ISIN
US23725P1003
Symbol
DRIO
Sector

Key metrics

Market capitalization $23.04m
Enterprise Value $37.12m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.61
P/S ratio (TTM) P/S ratio 1.00
P/B ratio (TTM) P/B ratio 0.32
Revenue growth (TTM) Revenue growth -2.09%
Revenue (TTM) Revenue $23.05m
EBIT (operating result TTM) EBIT $-59.45m
Free Cash Flow (TTM) Free Cash Flow $-39.37m
Cash position $16.41m
EPS (TTM) EPS $-0.97
P/E forward negative
P/S forward 0.86
EV/Sales forward 1.38
Short interest 8.76%
Show more

Is DarioHealth Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

DarioHealth Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a DarioHealth Corp. forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a DarioHealth Corp. forecast:

Buy
67%
Hold
33%

Financial data from DarioHealth Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
23 23
2% 2%
100%
- Direct Costs 14 14
7% 7%
60%
9.20 9.20
7% 7%
40%
- Selling and Administrative Expenses 39 39
17% 17%
168%
- Research and Development Expense 23 23
11% 11%
100%
-53 -53
16% 16%
-229%
- Depreciation and Amortization 6.77 6.77
32% 32%
29%
EBIT (Operating Income) EBIT -59 -59
18% 18%
-258%
Net Profit -32 -32
43% 43%
-140%

In millions USD.

Don't miss a Thing! We will send you all news about DarioHealth Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DarioHealth Corp. Stock News

Neutral
Business Wire
6 days ago
NEW YORK--(BUSINESS WIRE)---- $DRIO #GLP1--PESG Releases Report: In a healthcare market brimming with potential, DarioHealth Corp. (Nasdaq: DRIO)* is quietly emerging as a standout player, combining cutting-edge technology with proven outcomes. Looking at recent achievements, it seems DarioHealth's multi-condition digital health platform and its accelerating financial trajectory may position it...
Neutral
PRNewsWire
15 days ago
Significant participation from existing shareholders and accredited healthcare investors, which the company believes underscores confidence in its strategy Financing supports execution of long-term growth initiatives focused on high-margin, scalable recurring revenues across B2B (Business-to-Business) and pharma channels NEW YORK , Jan. 21, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ...
Neutral
Business Wire
22 days ago
NEW YORK--(BUSINESS WIRE)--Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The company's latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a larger share of this lucrative space as demand for medical wei...
More DarioHealth Corp. News

Company Profile

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

Head office United States
CEO Erez Raphael
Employees 276
Founded 2011
Website www.dariohealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today